TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 142 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $24,250,000 | -9.7% | 2,500,000 | 0.0% | 0.49% | +3.8% |
| Q1 2021 | $26,850,000 | -13.1% | 2,500,000 | +19.0% | 0.47% | -28.5% |
| Q4 2020 | $30,891,000 | +44.9% | 2,100,000 | +40.0% | 0.66% | +28.2% |
| Q3 2020 | $21,315,000 | +176.5% | 1,500,000 | +57.4% | 0.52% | +139.4% |
| Q2 2020 | $7,710,000 | +90.8% | 953,000 | -4.7% | 0.22% | +26.3% |
| Q1 2020 | $4,040,000 | +3980.8% | 1,000,000 | +566.7% | 0.17% | +4175.0% |
| Q1 2019 | $99,000 | -61.5% | 150,000 | 0.0% | 0.00% | -60.0% |
| Q4 2018 | $257,000 | -70.5% | 150,000 | 0.0% | 0.01% | -56.5% |
| Q3 2018 | $870,000 | -3.3% | 150,000 | 0.0% | 0.02% | +21.1% |
| Q2 2018 | $900,000 | -16.7% | 150,000 | 0.0% | 0.02% | +35.7% |
| Q1 2018 | $1,080,000 | -0.7% | 150,000 | 0.0% | 0.01% | -12.5% |
| Q4 2017 | $1,088,000 | – | 150,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
| Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
| COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
| Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
| Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
| ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
| NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
| Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
| Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |